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Abstract
Background: The first European Perinatal Health Report showed wide variability between European countries in fetal (2.6–
9.1%) and neonatal (1.6–5.7%) mortality rates in 2004. We investigated gestational age patterns of fetal and neonatal
mortality to improve our understanding of the differences between countries with low and high mortality.
Methodology/Principal Findings: Data on 29 countries/regions participating in the Euro-Peristat project were analyzed.
Most European countries had no limits for the registration of live births, but substantial variations in limits for registration of
stillbirths before 28 weeks of gestation existed. Country rankings changed markedly after excluding deaths most likely to be
affected by registration differences (22–23 weeks for neonatal mortality and 22–27 weeks for fetal mortality). Countries with
high fetal mortality $28 weeks had on average higher proportions of fetal deaths at and near term ($37 weeks), while
proportions of fetal deaths at earlier gestational ages (28–31 and 32–36 weeks) were higher in low fetal mortality countries.
Countries with high neonatal mortality rates $24 weeks, all new member states of the European Union, had high
gestational age-specific neonatal mortality rates for all gestational-age subgroups; they also had high fetal mortality, as well
as high early and late neonatal mortality. In contrast, other countries with similar levels of neonatal mortality had varying
levels of fetal mortality, and among these countries early and late neonatal mortality were negatively correlated.
Conclusions: For valid European comparisons, all countries should register births and deaths from at least 22 weeks of
gestation and should be able to distinguish late terminations of pregnancy from stillbirths. After excluding deaths most
likely to be influenced by existing registration differences, important variations in both levels and patterns of fetal and
neonatal mortality rates were found. These disparities raise questions for future research about the effectiveness of medical
policies and care in European countries.
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Introduction
In December 2008, the Euro-Peristat network produced the first
European Perinatal Health Report (EPHR) with data from 25
participating EU member states and Norway [1]. This report
showed great variations between European countries in fetal and
neonatal mortality rates in 2004 [1–3]. The highest mortality rates
were approximately 3.5 times higher than the lowest. Fetal
mortality rates ranged from 2.6 to 9.1 per 1000 total births, and
neonatal mortality rates from 1.6 to 5.7 per 1000 live births. The
EPHR also showed that, despite efforts of the World Health
Organization (WHO) to promote the use of common inclusion
criteria, there were still substantial differences in limits for
registration of live and stillbirths in Europe in 2004, especially
stillbirths [4]. These registration differences could be one
explanation for the observed variability between countries.
Preterm birth is an important risk factor for mortality during the
perinatal period and a key to understanding the etiology of both
fetal and neonatal deaths. One of the recommendations of the
Euro-Peristat project was therefore to collect and present data on
fetal and neonatal mortality by gestational age to allow for
exclusion of gestational age groups when differences in registration
are most marked and to permit more meaningful analysis of
variations between countries by comparing gestational age-specific
mortality rates. Differences in health care policies and practices
may contribute to the variation in observed fetal and neonatal
mortality rates by gestational age, including, for instance, policies
related to screening and terminations for congenital anomalies [5–
PLoS ONE | www.plosone.org 1 November 2011 | Volume 6 | Issue 11 | e247276]. In countries where terminations are not legal, some babies with
severe congenital anomalies probably die at later gestational ages
either during pregnancy or during the neonatal period. In other
countries, these pregnancies are more likely to be terminated at
earlier gestational ages. Furthermore, prevention strategies for
reducing mortality may differ for very preterm versus at and near
term births between European countries. For instance, programs
to improve the regionalization of perinatal care can contribute to
reduced mortality in the very preterm population [7].
The aim of this study was to analyze gestational age-related
differences in fetal and neonatal mortality between countries in
order to assess which part of inter-country variation is due to
variations in registration of births and deaths and which part is due
to real differences in health and quality of care. We also sought to
improve our understanding of differences between low versus high
mortality countries by identifying patterns of mortality by
gestational age. The following research questions will be
addressed: (i) How did preterm deaths, and in particular early
preterm deaths, contribute to differences in the variability of fetal
and neonatal mortality rates? (ii) Were absolute mortality rates
associated with a specific pattern? That is, did countries with low
mortality rates have higher proportions of preterm deaths (which
might be considered less preventable) and did high mortality
countries have higher proportions of at and near term deaths? (iii)
How did the timing of mortality (fetal/early neonatal/late
neonatal) differ in countries with high versus low mortality?
Methods
This study was embedded within the Euro-Peristat project,
which developed a list of valid and reliable indicators for
monitoring and evaluating perinatal health in the European
Union [8]. Twenty-five EU member states and Norway partici-
pated. Detailed information on the design and methods of the
Euro-Peristat project is available elsewhere [4,9–10].
Data collection was coordinated in the Netherlands. Data about
29 countries/regions for the year 2004 were analyzed: Austria (AT),
Belgium (BE): regions Brussels (BE.BR) and Flanders (BE.FL),
Cyprus (CY), Czech Republic (CZ), Denmark (DK), Estonia (EE),
Finland (FI), France (FR), Germany (DE), Greece (GR), Hungary
(HU), Ireland (IE), Italy (IT), Latvia (LV), Lithuania (LT),
Luxembourg (LU), Malta (MT), the Netherlands (NL), Norway
(NO), Poland (PL), Portugal (PT), Slovenia (SI), Slovakia (SK),
Spain or the Valencia region of Spain (ES), Sweden (SE), and the
United Kingdom (UK): England and Wales combined (UK.EW),
Northern Ireland (UK.NI), and Scotland (UK.SC).
Euro-Peristat definitions
Within Euro-Peristat the fetal mortality rate is defined as the
number of deaths before or during birth at or after 22 completed
weeks of gestation in a given year per 1000 live and stillbirths in
the same year. The neonatal mortality rate is defined as the
number of deaths during the neonatal period (day 0 to 27) at or
after 22 completed weeks of gestation in a given year expressed per
1000 live births in the same year. Early preterm deaths were
defined as deaths that occurred at 22–27 weeks of gestation, and at
and near term deaths as deaths at 37 weeks and above.
Availability of fetal and neonatal mortality
If participating countries/regions were unable to provide
numbers on fetal and neonatal mortality according to the Euro-
Peristat definition, the local definition was used. Cyprus provided
no data on fetal mortality, and the data from Greece and Italy
were for 2003. Information on fetal deaths with and without TOP
was collected afterwards, when it appeared that TOP were not
systematically included as fetal deaths.
All countries/regions provided data on neonatal mortality.
Ireland provided data only on early neonatal mortality and
Germany only on early neonatal mortality by gestational age.
Cyprus, the Czech Republic, Greece, Hungary, and Italy provided
no data on neonatal mortality by gestational age.
Spanish data by gestational age came only from the Valencia
region. Data from France by gestational age was based on several
sources: a one-week national perinatal survey that was conducted
in October 2003, vital registration, and neonatal death certificates.
Data on the gestational age distribution for live births from
England and Wales related to 2005, since these data were not
available at a national level before. Detailed information on the
data sources used is presented in Table S1.
Statistical analysis
The annual number of births ranged from 3902 to 774 870.
France, Germany, England and Wales, and Italy were among the
countries with more than 500 000 births, while Malta, Luxem-
bourg, and Cyprus had less than 10 000. We therefore calculated
confidence intervals using the binomial distribution to deal with
statistical variation of observed mortality rates between countries.
Rates were not calculated if there were fewer than 10 births. Rates
based on fewer than 10 deaths are noted in the tables.
Low and high mortality countries were defined by choosing the
25
th and 75
th percentiles respectively as cut-off levels. Differences in
the proportions of fetal/neonatal deaths between low versus high
mortality countries were tested with the x
2-test. We used the non-
parametric Spearman test to assess correlations and thus minimize
the effects of outliers. Spearman’s rho (r) was used to interpret the
strength of correlations. All analyses were performed with SPSS
version 17.0 for Windows (SPSS Inc, Chicago, IL, USA).
Results
Registration of live and stillbirths
Table 1 shows that most European countries had no limits for
registration of live births in 2004, but that the legal limits for
registration of stillbirths varied substantially. In some countries
stillbirths weighing less than 500 grams were not registered, while
other countries had a legal gestational age limit of 24 or even 28
weeks.Becauseof this Hungary andSwedencould not adhereto the
Euro-Peristat definition of 22 completed weeks of gestation for
stillbirths in 2004. Voluntary notification of late fetal deaths at 22–
23weeksexistedinthe UnitedKingdomandPortugal and therefore
Portugal, Northern Ireland, and Scotland were able to include these
deaths in their data. Italy and Luxembourg had a legal limit for
registration of180daysof pregnancy, butlate fetal deathsstarting at
22 weeks were available inthe register of spontaneous abortions and
were included. Table 1 also indicates that most countries did not
include TOP as fetal deaths. Exceptions were France, the Nether-
lands and Scotland. Elsewhere TOP were registered separately and
not included in national mortality statistics.
Variation in fetal and neonatal mortality rates
A large range was observed for overall fetal (2.6–9.1%) and
neonatal (1.6–5.7%) mortality rates in the 28 participating
countries/regions, as shown in Table 2. In these countries/
regions, 25 360 fetal deaths and 4 733 268 births, and 14 212
neonatal deaths and 4 713 200 live births were registered. The
proportion of fetal deaths represented by TOP varied between
countries, as measured by supplemental data provided by a few
countries (data not shown in table). If TOP were included as fetal
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5.9% in England and Wales (3.3% were TOP), from 3.2% to
3.7% in Finland (16% were TOP), and from 5.4% to 6.9% in
Italy (28% were TOP). After excluding TOP, the fetal mortality
rate in Scotland would have declined from 6.7% to 6.6% (2.5%
were TOP), and the Netherlands estimated that their fetal
mortality rate would have declined from 7.0% to 6.8% after
excluding TOP (2.9% were TOP).
Exclusion of early preterm deaths
Figure 1 illustrates fetal and neonatal mortality rates by
gestational-age subgroups and ranks countries by their mortality
rate at 28 weeks and over. Excluding early preterm deaths reduced
the range of fetal mortality rates quite substantially, while a
moderate reduction was observed for neonatal mortality rates. For
many countries, deaths before 28 weeks of gestation accounted for
a substantial proportion of all deaths. Countries with the highest
overall fetal mortality rates did not necessarily have the highest
fetal mortality rates at or after 28 weeks of gestation, and not all
countries with the highest neonatal mortality rates had the highest
neonatal mortality rates at or after 28 weeks of gestation. The fetal
mortality rate declined dramatically for France when fetal deaths
at 22–27 weeks were excluded and removing neonatal deaths at
22–23 weeks led to a large decline in neonatal mortality rates in
the Netherlands, Northern Ireland, and England and Wales.
Adjusted proportions of fetal and neonatal deaths
Figure 2 presents the percentage of fetal and neonatal deaths in
each gestational age subgroup after excluding fetal deaths at 22–27
weeks and neonatal deaths at 22–23 weeks. The percentage of fetal
Table 1. Criteria for registration of live births and stillbirths and inclusion of terminations of pregnancy in Europe in 2004.
Live births Stillbirths TOP included
TOP included in a
separate data
system
Austria No limit $500 grams No No
BE: Brussels No limit $22 weeks or $500 grams No No
BE: Flanders No limit $500 grams No No
Cyprus No limit No data available No data available
Czech Republic $500 grams or any birth weight
surviving the first 24 hours
$22 weeks No Yes
Denmark No limit $22 weeks No Yes
Estonia No limit $22 weeks or $500 grams No Yes
Finland No limit $22 weeks or $500 grams No Yes
France $22 weeks or $500 grams $22 weeks or $500 grams Yes No
Germany No limit $500 grams No Yes
Greece No limit legal limit of $28 weeks No No
Hungary No limit $24 weeks or $500 grams No Yes
Ireland No limit $24 weeks or $500 grams TOP is not legal and not performed
Italy No limit 180 days No Yes
Latvia No limit $22 weeks No Yes
Lithuania $22 weeks $22 weeks No Yes
Luxembourg No limit 180 days No No
Malta No limit $22 weeks or $500 grams TOP is illegal and not performed
The Netherlands $22 weeks or $500 grams $24 weeks for civil registration
$16 weeks for perinatal registry
Yes Yes
Norway $12 weeks $12 weeks No Yes
Poland $500 grams $500 grams No Yes
Portugal No limit $24 weeks No No
Slovakia No limit $22 weeks or $500 grams No Yes
Slovenia No limit $500 grams No Yes
Spain No limit $26 weeks (national)
$22 weeks (region Valencia)
No Yes
Sweden No limit $28 weeks No Yes
UK: England and Wales No limit legal limit of $24 weeks voluntary
notification at 22–23 weeks
Yes Yes
UK: Northern Ireland No limit legal limit of $24 weeks voluntary
notification at 22–23 weeks
TOP is not legal*
UK: Scotland No limit legal limit of $24 weeks voluntary
notification at 22–23 weeks
Yes Yes
*The legislation which legalised abortion in the rest of the United Kingdom does not cover Northern Ireland, but TOP are occasionally done there under case law.
doi:10.1371/journal.pone.0024727.t001
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between low and high fetal mortality countries (p,0.001). On
average, low fetal mortality countries had higher percentages of
their fetal deaths at earlier gestational ages (at 28–31 weeks 24.5%
vs. 22.9%, at 32–36 weeks 36.3% vs. 32.9%), while high fetal
mortality countries had higher percentages at and near term (44.2%
vs. 39.2%). In contrast, the percentage of neonatal deaths in each
gestational age subgroup did not differ significantly between low
and high neonatal mortality countries (p=0.112): at 24–27 weeks
(30.0% vs. 31.7%), at 28–31 weeks (17.4% vs. 19.5%), at 32–36
weeks (18.5% vs. 19.6%), and at 37+ weeks (34.1% vs. 29.2%).
Indeed, on average, high neonatal mortality countries had lower
percentages of neonatal deaths at and near term.
Gestational age-specific neonatal mortality rates
Table 3 provides data on gestational age-specific neonatal
mortality for those countries that could provide both numerator
and denominator data for the gestational age distribution.
Substantial variation existed within all gestational age subgroups,
even when rates based on small denominators were excluded.
Countries with high neonatal mortality rates at or after 24 weeks of
gestation (Latvia, Poland, Malta, Lithuania, and Estonia) often had
the highest gestational age-specific neonatal mortality rates for all
gestational age subgroups, except at 22–23 weeks. Some countries
stood out in some subgroups. The Netherlands, for instance, had
high rates at 22–23 weeks and at 24–27 weeks, while Denmark
had high rates at 22–23 weeks and at 37+ weeks.
Correlation between fetal and neonatal mortality rates
Although fetal mortality rates at or after 28 weeks and neonatal
mortality rates at or after 24 weeks were significantly correlated
(r=0.646; p=0.001), different patterns were observed for low
versus high neonatal mortality countries. Figure 3 shows that high
neonatal mortality countries had high fetal mortality rates, but
countries with low and moderate neonatal mortality rates had
varying levels of fetal mortality. Finland, Czech Republic,
Table 2. Fetal and neonatal mortality rates in Europe in 2004.
Country/region
Number of
total births
Number of
fetal deaths
Fetal Mortality Rates
per 1000 total births
Number of live
births
Number of
neonatal deaths
Neonatal Mortality
Rates per 1000 live
births
Austria 79 229 295 3.7 [3.3–4.1] 78 934 215 2.7 [2.4–3.1]
BE: Brussels 16 288 88 5.4 [4.3–6.5] 16 200 51 3.4 [2.3–4.0]
BE: Flanders 60 921 249 4.1 [3.6–4.6] 60 672 146 2.4 [2.0–2.8]
Cyprus NA NA NA 8 309 13 1.6 [0.7–2.4]
Czech Republic 98 051 387 3.9 [3.6–4.3] 97 671 224 2.3 [2.0–2.6]
Denmark 64 853 332 5.1 [4.6–5.7] 64 521 230 3.6 [3.1–4.0]
Estonia 14 053 63 4.5 [3.4–5.6] 13 990 59 4.2 [3.1–5.3]
Finland 57 759 190 3.3 [2.8–3.8] 57 569 141 2.4 [2.0–2.9]
France 774 870 7 054 9.1 [8.9–9.3] 767 816 1968 2.6 [2.5–2.7]
Germany 648 860 2 261 3.5 [3.3–3.6] 705 622 1892 2.7 [2.6–2.8]
Greece 104 858 503 4.8 [4.4–5.2] 104 355 282 2.7 [2.4–3.0]
Hungary 95 594 476 5.0 [4.5–5.4] 95 137 423 4.4 [4.0–4.9]
Ireland 62 400 334 5.4 [4.8–5.9] 62 066 NA NA
Italy 542 003 2 937 5.4 [5.2–5.6] 539 066 1526 2.8 [2.7–3.0]
Latvia 20 492 137 6.7 [5.6–7.8] 20 355 116 5.7 [4.7–6.7]
Lithuania 29 633 153 5.2 [4.3–6.0] 29 480 136 4.6 [3.8–5.4]
Luxembourg 5 486 17 3.2 [1.6–4.6] 5 469 11 2.0 [0.8–3.2]
Malta 3 902 15 3.8 [1.9–5.8] 3 887 17 4.4 [2.3–6.4]
The Netherlands 182 279 1 273 7.0 [6.6–7.4] 181 006 631 3.5 [3.2–3.8]
Norway 57 368 257 4.5 [3.9–5.0] 57 111 118 2.1 [1.7–2.4]
Poland 358 440 1 743 4.9 [4.6–5.1] 356 697 1731 4.9 [4.6–5.1]
Portugal 109 778 422 3.8 [3.5–4.2] 109 356 280 2.6 [2.3–2.9]
Slovak Republic 52 522 134 2.6 [2.1–3.0] 52 388 134 2.6 [2.1–3.0]
Slovenia 17 946 100 5.6 [4.5–6.7] 17 846 47 2.6 [1.9–3.4]
Spain 456 029 1 438 3.2 [3.0–3.3] 454 591 1199 2.6 [2.5–2.8]
Sweden 100 474 316 3.1 [2.8–3.5] 100 158 210 2.1 [1.8–2.4]
UK: England and Wales 643 407 3 686 5.7 [5.5–5.9] 639 721 2185 3.4 [3.3–3.6]
UK: Northern Ireland 22 504 142 6.3 [5.3–7.3] 22 362 66 3.0 [2.2–3.7]
UK: Scotland 53 269 358 6.7 [6.0–7.4] 52 911 161 3.0 [2.6–3.5]
Cyprus provided no data on fetal death. Ireland only provided data on early neonatal death.
Data for countries that did not adhere to the Euro-Peristat definition are presented in italics.
High mortality rates (.75
th quartile) are presented in bold.
doi:10.1371/journal.pone.0024727.t002
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neonatal mortality rates of 2.0%, but their fetal mortality ranged
from 2.0% through 3.5%. The correlation between fetal and
neonatal mortality increased with increasing gestational age and
was closest when all preterm deaths were excluded (r=0.758;
p,0.001), see Figure S1.
Correlation between early and late neonatal mortality
rates
Early and late neonatal mortality were related in different ways
in countries with high (r=0.261; p=0.618) versus low and
moderate (r=20.302; p=0.184) neonatal mortality, as Figure 4
shows. Countries with high neonatal mortality had high rates of
both early and late neonatal mortality, while different patterns
were observed in other countries: some countries had high early
neonatal mortality, but low late neonatal mortality (e.g. the
Netherlands and Denmark) and several other countries had low
early neonatal mortality and high late neonatal mortality. Early
neonatal mortality was related to total neonatal mortality in all
countries (r=0.915; p,0.001), but late neonatal mortality was
related to total neonatal mortality only in countries with high
neonatal mortality (r=0.812; p=0.05), see Figure S2.
Discussion
Our analysis shows that early preterm deaths, most strongly
influenced by registration differences, contributed substantially
to the variation in fetal and neonatal mortality rates in Europe
in 2004. But even after these early preterm deaths were
excluded, fetal and neonatal mortality rates varied notably and
in all gestational age subgroups, including those at and near
term. In addition, patterns of mortality differed for the
gestational age at which highest mortality was observed and
for the association between fetal and neonatal mortality
rates.
Our study has several limitations linked to measurement and
data availability, despite efforts within Euro-Peristat to ensure
comparability in definitions and sources. The first limitation is
related to our ability to assess the completeness of registration of
early preterm births, especially stillbirths [11]. Although we were
able to describe registration rules, our lack of knowledge about the
extent to which these were applied uniformly in all countries limits
our ability to assess real fetal mortality at 22–27 weeks and real
neonatal mortality at 22–23 weeks. A related issue is the
registration of TOP, which is managed very differently from one
country to another and terminations are not always included as
fetal deaths. TOP varied from 3 to 28% of total fetal deaths in
those countries where this proportion could be computed. In
France an even larger proportion of early fetal deaths are
estimated to be TOP [12–13]. To our knowledge, this limitation
affects all stillbirth data routinely reported to international
agencies. This issue has not previously been highlighted, even
though the influence of TOP on fetal mortality rates has been
discussed in previous studies [14–15].
Figure 1. Impact of different inclusion criteria on fetal and neonatal mortality rates. Countries were sorted by mortality rate at or after 28
weeks of gestation with low mortality countries listed first.
doi:10.1371/journal.pone.0024727.g001
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PLoS ONE | www.plosone.org 6 November 2011 | Volume 6 | Issue 11 | e24727The different sources of data used by each country may also
affect comparability [4,16]. Some countries provided mortality
data from civil or perinatal registries or both, by linkage. These
differences in methods may lead to differences in coverage [4].
The number of annual births in each country also varied greatly
throughout Europe, from 3902 to 774 870, and random variability
from year to year is high when rates are based on small numbers.
In Malta, for example, the relatively high gestational age-specific
neonatal mortality rate at 28–31 weeks of 238% (5 out of 21
babies died) in 2004 fell drastically to 59% in the two subsequent
years (1 out of 17 babies died in both 2005 and 2006) [17]. In
addition, not all countries were able to provide national data;
instead, some used either representative samples or regional
population-based data. We addressed the question of small sample
sizes by calling attention to rates based on fewer than 10 deaths,
not reporting those based on fewer than 10 births, and presenting
confidence intervals.
A final limitation is related to the comparability of reported
gestational ages. Euro-Peristat requested data in completed weeks
of gestation based on the best obstetrical estimate available, but we
were unable to assess or evaluate differences in the measurement
of gestational age. Preterm birth rates may differ depending to
whether they are measured by last menstrual period or by
ultrasound [18–19]. Use of ultrasound measurements, by shifting
the entire gestational age distribution to the left, can increase the
preterm birth rate [18], but it can also decrease the rate by
Figure 2. Fetal deaths at or after 28 weeks of gestation (A) and neonatal deaths at or after 24 weeks (B) by gestational age
subgroups. Countries were sorted by fetal (A) and neonatal (B) mortality rates with low mortality countries listed first. Fetal mortality rate at or after
28 weeks of gestation was calculated as follows: [(number of fetal deaths $28 weeks)/(number of total births $28 weeks)]61000. France, Latvia,
Scotland, Ireland and The Netherlands had rates in the top quartile (.75th). * Percentages of fetal deaths were based on fewer than 10 events for
Luxembourg and Malta, and for Estonia (at 28–31 and 32–36 weeks). Neonatal mortality rate at or after 24 weeks of gestation was calculated as
follows: [(number of neonatal deaths $24 weeks)/(number of live births $24 weeks)]61000. Latvia, Poland, Malta, Lithuania, and Estonia had
mortality rates in the top quartile (.75th). * Percentages of neonatal death were based on less than 10 events for Luxembourg and Malta, for
Brussels, Estonia, and Slovenia (at 28–31 weeks and at 32–36 weeks), and for Northern Ireland (at 28–31 weeks).
doi:10.1371/journal.pone.0024727.g002
Table 3. Gestational age-specific neonatal mortality rates per 1000 live births.
Country/region Gestational age in weeks
22–23 24–27 28–31 32–36 $37
Luxembourg – – * 76.9 [0.0–222] * 9.7 [0.0–20.7] * 0.6 [0.0–1.3]
Czech Republic 546 [337–754] 218 [170–266] 52.1 [36.2–68.0] 5.9 [3.9–7.9] 0.5 [0.4–0.7]
Norway 556 [326–785] 185 [126–243] 46.6 [26.1–67.0] 4.3 [2.1–6.5] 0.8 [0.6–1.1]
ES: Valencia – 302 [215–389] 67.4 [41.4–93.5] 3.5 [1.7–5.4] 0.5 [0.3–0.7]
Sweden 485 [314–655] 167 [121–212] 33.4 [19.3–47.4] 8.9 [6.4–11.4] 0.9 [0.7–1.1]
Finland 867 [745–988] 293 [216–371] 52.6 [29.0–76.3] 6.0 [3.0–8.9] 0.7 [0.5–1.0]
BE: Flanders 1000 [1000–1000] 311 [237–385] 51.5 [29.5–73.5] 7.2 [4.7–9.8] 0.6 [0.4–0.8]
Austria 867 [767–966] 230 [182–279] 37.4 [24.0–50.7] 4.1 [2.7–5.5] 0.7 [0.5–0.9]
Slovenia – 308 [182–433] * 36.5 [5.1–67.9] * 7.6 [2.4–12.9] 0.7 [0.3–1.1]
Portugal 338 [285–391] 54.9 [38.2–71.7] 6.7 [4.7–8.8] 0.7 [0.6–0.9]
France – – – – 0.8 [0.8–0.9]
UK: Northern Ireland – 244 [151–337] * 30.3 [4.1–56.5] 9.0 [3.7–14.3] 0.8 [0.4–1.2]
Slovakia 600 [352–848] 281 [203–359] 86.0 [56.6–115.4] 11.8 [7.8–15.8] 0.5 [0.3–0.7]
UK: England and
Wales{
903 [880–926] 237 [220–254] 36.6 [31.7–41.4] 6.1 [5.3–6.9] 0.9 [0.9–1.0]
UK: Scotland – 301 [234–367] 47.3 [27.6–67.0] 4.7 [2.4–7.0] 0.8 [0.6–1.1]
The Netherlands 976 [950–1000] 325 [282–368] 54.5 [42.2–66.7] 7.5 [5.9–9.1] 1.1 [1.0–1.3]
Denmark 947 [847–1000] 289 [220–358] 38.2 [21.3–55.0] 8.2 [5.3–11.1] 1.6 [1.3–2.0]
BE: Brussels – 320 [191–449] * 84.9 [31.8–138] * 6.6 [1.3–11.8] 1.3 [0.7–1.9]
Estonia – 321 [195–446] * 47.1 [2.0–92.1] * 8.8 [1.8–15.8] 2.1 [1.3–2.8]
Lithuania 786 [571–1000] 488 [378–597] 90.9 [49.7–132] 13.2 [6.9–19.4] 1.9 [1.4–2.4]
Malta – – * 238 [55.9–420] * 15.9 [0.4–31.3] * 1.4 [0.2–2.6]
Poland 875 [822–928] 457 [428–486] 125 [112–137] 16.2 [14.5–17.9] 1.2 [1.1–1.4]
Latvia – 477 [356–598] 82.9 [42.7–123] 15.3 [7.3–23.2] 2.7 [2.0–3.4]
Cyprus, Germany, Greece, Hungary, Ireland, and Italy had no data on neonatal death by gestational age. { Data from 2005.
Countries were sorted by neonatal mortality rate at or after 24 weeks of gestation with low mortality countries listed first.
High mortality rates are presented in bold (.75
th quartile). Rates based on fewer than 10 deaths were denoted with *.
Rates were not computed for cells with fewer than 10 births and were denoted with –.
For France the number of term live births was estimated from the national perinatal survey and totals from the vital statistics data.
doi:10.1371/journal.pone.0024727.t003
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PLoS ONE | www.plosone.org 7 November 2011 | Volume 6 | Issue 11 | e24727Figure 3. Correlation between fetal and neonatal mortality rates, after exclusion of deaths most likely influenced by registration
differences. High mortality countries are presented in bold. Correlation for fetal and neonatal mortality: r=0.646 (p=0.001).
doi:10.1371/journal.pone.0024727.g003
Figure 4. Correlation between early and late neonatal mortality rates. High neonatal mortality countries are presented in bold. r=0.261
(p=0.618) in high neonatal mortality countries versus r=20.302 (p=0.184) in other countries.
doi:10.1371/journal.pone.0024727.g004
Patterns of Fetal and Neonatal Mortality in Europe
PLoS ONE | www.plosone.org 8 November 2011 | Volume 6 | Issue 11 | e24727reducing errors in gestational age estimates [20]. In most
European countries, however, dating ultrasounds are now part
of standard care during pregnancy, and most women have their
first prenatal visit in the first trimester [1].
The Euro-Peristat project chose to collect mortality data using a
cut-off point of 22 completed weeks of gestation without a birth
weight limit, although data were also collected by birth weight to
permit calculation of rates with a lower limit of 1000 grams as
recommended by WHO for international comparisons. While the
WHO definition of the perinatal period is based on gestational age
(starting at 22 weeks of gestation), recommendations for data
collection are based primarily on birth weight (death of a fetus that
has reached a birth weight of 500 grams or if the birth weight is
unavailable, a gestational age of 22 completed weeks or a crown-
to-heel length of 24 cm is used) [21]. These international
recommendations are understandable because in many countries
valid data on gestational age simply do not exist, although it is not
clear that stillbirths are systematically weighed [22]. In Europe,
however, legislation for registering stillbirths is based largely on
gestational age. Regulations governing TOP are also specified with
respect to the length of gestation [13].
It is important to note that gestational age-specific mortality
data are not produced routinely by any international or European
agency (including EUROSTAT, OECD or WHO) and have not,
to our knowledge, ever been published in this way from routine
data. Our analyses require the collection of fetal and neonatal
(both early and late) deaths by individual week of gestation and
these are not routinely provided, even in many national
publications. A further strength of our analysis is the number of
countries that contributed.
From an analytic perspective, gestational-age based analyses are
important because they distinguish premature birth from fetal
growth restriction. Recent European cohorts of very preterm
infants are based on gestational age because of its superior
prognostic value [23] and because information on gestational age,
and not on birth weight, is available to obstetricians when making
decisions during pregnancy and delivery [24–27]. Gestational age
comparisons across Europe avoid biases related to population
differences in birth weight; European comparisons have found that
optimum birth weight, defined as the birth weight at which
mortality is lowest, varies between European countries [28].
Our analyses showed that it was necessary to exclude stillbirths
at 22–27 weeks and neonatal deaths at 22–23 weeks from
European comparisons to minimize the effect of differences in
registration requirements and TOP legislation on mortality rates.
As survival is rare for babies at 22–23 weeks, including this
gestational age group adds nearly as many deaths as births and
gives this subgroup a large weight in mortality statistics, although
they only represent about 1 in 1000 live births. These infants make
up a high proportion of fetal and neonatal deaths in some
countries. Although registration limits primarily affect fetal deaths,
fetal death registration is known to affect the completeness of live
birth registration, especially, for example, for those weighing less
than 500 grams. The limit of 500 grams primarily concerns infants
at 22–23 weeks, so excluding these infants also resolves the
problems of comparability presented by birth weight limits. By 24
weeks of gestation, most babies have a birth weight above 500
grams [29]. Some countries had substantially lower gestational
age-specific neonatal mortality at 22–23 weeks than reported in
specific studies of this population [30–31] suggesting that in some
countries many immediate neonatal deaths are simply not
registered as live births in birth registers. For fetal mortality, a
higher cut-off point was necessary to include Sweden, which only
registered fetal deaths starting at 28 weeks, as well as to deal with
problems of comparability raised by TOP notification. For valid
European comparisons of gestation-specific fetal and neonatal
mortality, all member states should aim to register fetal deaths
from 22 completed weeks of gestation, regardless of birth weight.
In July 2008, Sweden changed its limit for registration of stillbirths
from 28 to 22 completed weeks of gestation. This change will make
it possible to compare their stillbirth rates with other European
countries at earlier gestational ages in future studies.
Use of these exclusion criteria had a substantial impact on the
ranking of countries. Not all countries with the highest or lowest
mortality rates also had the highest or lowest fetal mortality rates at
or after 28 weeks or the highest or lowest neonatal mortality rates
at or after 24 weeks. It is thus very important for international
agencies to collect gestational age to allow like-with-like compar-
isons. In this light, EUROSTAT’s updated directives, which
makes provision of fetal and neonatal mortality by birth weight
voluntary for EU member states and does not even request
voluntary collection by gestational age, is a matter for concern
[32].
After exclusion of the early preterm deaths most likely to be
influenced by registration differences, the levels and patterns of
mortality still varied significantly between countries. The clearest
pattern observed was among countries with highest neonatal
mortality rates, all new member states of the European Union
(Latvia, Poland, Malta, Estonia, Lithuania, and Hungary). These
countries had high fetal mortality and high early and high late
neonatal mortality rates. This finding suggests that some of the
causes may be related to overall standards of living and resources
available to the health care system. For Poland and Malta, the
restricted availability (Poland) and illegality of TOP (Malta) may
also contribute to higher rates.
In contrast, we observed different levels of fetal mortality in
other countries with the same overall level of neonatal mortality.
Medical advances, such as antenatal steroids and surfactant for
very preterm babies, have been very successful in decreasing
neonatal mortality, perhaps contributing to more convergent
trends in neonatal mortality in countries with similar access to
these technologies. In contrast, preventing stillbirths may be more
complex. Stillbirths are strongly related to maternal social
characteristics, high body mass index and smoking [33–34]. The
prevalence of these risk factors and health system programs to
reduce their impact may differ across countries. Factors suggesting
sub-optimal care are associated with a substantial proportion of
stillbirths, especially for intrapartum deaths [35].
We also found that some countries had higher mortality in some
gestational age subgroups. Denmark, for example, had both high
proportions of fetal and neonatal deaths at 37+ weeks, and a high
gestational age-specific neonatal mortality rate at 37+ weeks, but
was not defined as a high mortality country when comparing rates
at earlier gestational ages. France, on the other hand, had the
highest fetal mortality rate at or after 28 weeks, but did not have a
high proportion of fetal deaths at and near term.
Differences in policies and practices may explain these varying
patterns of mortality. For instance, policies related to screening
and terminations for congenital anomalies differ in Europe and
can have a large impact on both fetal and neonatal mortality rates
[5–6]. TOP could be performed legally around 2004 in most
European countries, although the maximum gestational age limit
varied and the notification procedures differed. Exceptions were
Ireland, Northern Ireland and Malta, where TOP are not legal
and cannot be performed. It is possible that some pregnancies that
were found to have lethal congenital anomalies from these
countries were terminated elsewhere or that fewer of these
pregnancies were terminated; in the latter cases, these babies,
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included in their mortality statistics. Policies related to TOP may
explain the relatively high proportion of fetal deaths at and near
term in the Netherlands, which, unlike most other European
countries in 2004, had no system for systematic early detection of
congenital anomalies through prenatal screening. On the other
hand, countries that systematically screened at earlier gestational
ages and terminated more before the registration limit necessarily
have lower mortality rates, both fetal and neonatal [13–14]. In
contrast, countries that practice terminations at or after 22 weeks
may end up with high stillbirth rates explained primarily by
terminations. France is one example [13]. Late terminations for
fetal anomalies are rare in Europe, and prevalence rates vary
between European countries [13]. Ideally, it should be possible to
remove TOP from fetal death statistics and to calculate rates with
and without TOP.
Another area where European countries differ is in policies and
attitudes to withdrawing and withholding care for preterm infants
at the limit of viability. This affects the types of care babies receive,
their survival probabilities and the timing of death [36–37].
Countries that are more likely to withhold care will have higher
mortality rates at early gestational ages; for example the Nether-
lands had high gestational age-specific neonatal mortality rates at
22–23 and at 24–27 weeks, because its active interventions for
these early preterm live births were much more limited than in
other European countries [36–37]. These policies may also affect
the proportion of infants that are live born at early gestational ages
after medically indicated cesareans [38]. Cesarean delivery rates
for infants born between 24 and 25 weeks, excluding cesareans for
maternal indications, varied from 0–78% between European
regions in 2003, for instance [39]. Without active intervention,
neonatal deaths also occur earlier. In the Netherlands, for
example, high early neonatal mortality rates but low late neonatal
mortality rates could reflect the lack of active intervention before
26 weeks of gestation [36]. Several other countries had low early
neonatal mortality rates, but high late neonatal mortality rates,
which may indicate that babies were living longer and dying in the
late neonatal period.
Finally, high mortality at and near term may reflect policies
related to the care of term pregnancies, including policies to
induce delivery for post-term infants, which may differ substan-
tially [40] and the organization of maternity services for low-risk
pregnancies which also varies greatly within Europe [41]. Having
data on causes of death and on timing of death (intrapartum or
antepartum) would add to Euro-Peristat’s capacity to explain
differences in levels and patterns of gestational age-specific
mortality and this will be a goal for future phases.
Conclusions
Registration differences contributed notably to the variability in
fetal and neonatal mortality rates between countries. All European
countries should use common inclusion criteria for the registration
of live and stillbirths. To allow a common analysis of gestation-
specific mortality, it is important to have data starting from at least
22 completed weeks of gestation. To comply with WHO
recommendations, this would require countries to collect data
using both gestational age (22 weeks) and birth weight (500 grams)
limits, as is already done in several European countries. Countries
should also be able to calculate fetal mortality rates with and
without late TOP. Nonetheless, differences in registration criteria
do not explain the variability in mortality rates between European
countries. Routine reporting of fetal and neonatal deaths by
gestational age improves the usefulness of these data for
surveillance and policy. Providing countries with international
references for neonatal and fetal mortality by gestational age
makes it possible for them to assess their specific weaknesses and
generate ideas about how to improve outcomes. These data also
raise important questions for future research about the tradeoffs
between fetal and neonatal mortality in many countries and the
reasons for differing gestational age-specific patterns in neonatal
mortality.
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Figure S1 Correlation between gestation-specific fetal
and neonatal mortality rates. Correlation for fetal and
neonatal mortality $22 weeks: r=0.502 (p=0.010). Correlation
for fetal and neonatal mortality $28 weeks: r=0.612 (p=0.002).
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